Circulating anti-SARS-CoV-2 nucleocapsid (N)-protein antibodies and anti-SARS-CoV-2 spike (S)-protein antibodies in an African setting: herd immunity, not there yet!

OBJECTIVE: Herd immunity is achieved when in a population, immune individuals are in a sufficiently large proportion. Neutralizing antibodies specific to SARS-CoV-2 that are produced following infection or vaccination are critical for controlling the spread of COVID-19. The objective of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Mveang Nzoghe, Amandine, Leboueny, Marielle, Kuissi Kamgaing, Eliane, Maloupazoa Siawaya, Anicet Christel, Bongho, Eliode Cyrien, Mvoundza Ndjindji, Ofilia, Padzys, Guy-Stephan, Ndeboko, Bénédicte, Ategbo, Simon, Djoba Siawaya, Joel Fleury
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056361/
https://www.ncbi.nlm.nih.gov/pubmed/33879229
http://dx.doi.org/10.1186/s13104-021-05570-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056361/
https://www.ncbi.nlm.nih.gov/pubmed/33879229
http://dx.doi.org/10.1186/s13104-021-05570-3

Ejemplares similares